News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,700 Results
Type
Article (22824)
Company Profile (117)
Press Release (201759)
Section
Business (57836)
Career Advice (212)
Deals (8982)
Drug Delivery (61)
Drug Development (44165)
Employer Resources (24)
FDA (5467)
Job Trends (5265)
News (113713)
Policy (9813)
Tag
Academia (1326)
Alliances (17591)
Alzheimer's disease (583)
Antibody-drug conjugate (ADC) (54)
Approvals (5428)
Artificial intelligence (40)
Bankruptcy (69)
Best Places to Work (4612)
Biosimilars (39)
Biotechnology (100)
Breast cancer (68)
Cancer (701)
Career advice (177)
CAR-T (62)
Cell therapy (207)
Clinical research (33304)
Collaboration (149)
Compensation (34)
COVID-19 (1165)
Cystic fibrosis (52)
Data (428)
Diabetes (41)
Diagnostics (2115)
Drug pricing (66)
Earnings (19906)
Events (34078)
Executive appointments (76)
FDA (5647)
Funding (111)
Gene editing (41)
Gene therapy (122)
GLP-1 (206)
Government (1404)
Healthcare (6851)
Infectious disease (1194)
Inflammatory bowel disease (48)
Interviews (42)
IPO (4543)
Job creations (795)
Job search strategy (153)
Layoffs (147)
Legal (1589)
Liver cancer (50)
Lung cancer (150)
Lymphoma (40)
Manufacturing (68)
Medical device (2258)
Medtech (2262)
Mergers & acquisitions (4468)
Metabolic disorders (105)
Neuroscience (696)
NextGen Class of 2024 (2079)
Non-profit (1336)
Northern California (473)
Obesity (57)
Opinion (77)
Patents (35)
People (15882)
Phase I (12536)
Phase II (15205)
Phase III (9792)
Pipeline (113)
Policy (48)
Postmarket research (828)
Preclinical (5811)
Press Release (57)
Radiopharmaceuticals (110)
Rare diseases (126)
Real estate (1468)
Regulatory (7385)
Research institute (1282)
Southern California (428)
Startups (1352)
United States (4405)
Vaccines (227)
Weight loss (48)
Date
Today (77)
Last 7 days (284)
Last 30 days (1214)
Last 365 days (15863)
2024 (12734)
2023 (17335)
2022 (21878)
2021 (22650)
2020 (20156)
2019 (15399)
2018 (11699)
2017 (11436)
2016 (10648)
2015 (12681)
2014 (8718)
2013 (7234)
2012 (7399)
2011 (7278)
2010 (6334)
Location
Africa (158)
Asia (15148)
Australia (2838)
California (1052)
Canada (358)
China (107)
Colorado (38)
Europe (31994)
Florida (119)
Illinois (92)
Maine (34)
Maryland (194)
Massachusetts (875)
Minnesota (80)
New Jersey (328)
New York (375)
North Carolina (236)
Northern California (473)
Ohio (52)
Pennsylvania (289)
South America (272)
Southern California (428)
Texas (152)
Washington State (211)
224,700 Results for "cell medica".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Donaldson Enters into Agreement to Acquire Minority Stake in Medica, S.p.A.
Donaldson Company, Inc., a leading worldwide provider of innovative filtration products and solutions, announced it has entered into a definitive agreement allowing the Company to purchase a 49% stake in Medica S.p.A.
April 29, 2024
·
5 min read
Press Releases
Phio Announces Data Showcasing INTASYL’s Role in Helping Immune Cells Target and Kill Cancer Cells
INTASYL compounds also improve the functionality and outcomes of adoptive cell therapies such as NK, TIL and CAR-T
October 7, 2024
·
3 min read
Drug Delivery
The Next Frontier: Industrializing Cell Therapy Manufacturing
Q&A: Development Scientist at AGC Biologics Sara Morlacchi analyzes the growth of the cell therapy industry and barriers for cost and accessibility.
April 29, 2024
·
7 min read
·
Sara Morlacchi, Cell Process Development Manager, AGC Biologics
Drug development
5 Sickle Cell Therapies to Watch Following Pfizer’s Oxbryta Exit
In the wake of Pfizer’s voluntary market withdrawal of the popular sickle cell disease therapy,
BioSpace
looks at five investigational drugs currently making their way through the pipeline.
October 21, 2024
·
4 min read
·
Kate Goodwin
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT’s 2024 Advancing Gene and Cell Therapies for Cancer Conference
PH-894: Potent and Specific Silencing of BRD4 in NK Cells
October 16, 2024
·
4 min read
Biotech Bay
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
Mainz Biomed N.V. announced that VP Commercial Operations, Tarrin Khairi-Taraki, will attend MEDICA by invitation of the Rhineland-Pfalz government.
November 7, 2023
·
3 min read
UroFiber SuperPulsed Thulium Fiber Laser System Officially Debuts at MEDICA 2023
UroFiber SuperPulsed Thulium Fiber Laser System, developed by Rhein Laser Technologies Ltd., a pioneer in medical laser technology, made its first appearance at the esteemed MEDICA 2023 in Germany.
November 30, 2023
·
2 min read
Cell and gene therapy
Cell and Gene Therapy Investment Ticks Up After Hard Few Years
Tim Hunt, CEO of the Alliance for Regenerative Medicine, said Monday at the 2024 Cell & Gene Meeting on the Mesa that investments reached $10.9 billion in the first half of this year—outpacing 2019’s $9.8 billion total—but far below the pandemic peak.
October 8, 2024
·
4 min read
·
Greg Slabodkin
1 of 22,470
Next
